News Releases
Prometheus Biosciences Appoints Joseph C. Papa to its Board of Directors
Aug 25, 2020
Prometheus Biosciences and Dr. Falk Pharma GmbH Announce Global Collaboration Agreement to Develop and Commercialize a Novel IBD Antibody
Aug 13, 2020
Prometheus Biosciences Appoints Keith W. Marshall as Chief Financial Officer
Aug 04, 2020
Precision IBD Announces Next Phase Of Growth: Appoints Mark C. McKenna As President And Chief Executive Officer, Completes Name Change To Prometheus Biosciences, Inc.
Sep 05, 2019
Displaying 31 - 34 of 34